Skip to content

The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis

The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis:a Real-world Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07283718
Enrollment
2467
Registered
2025-12-16
Start date
2025-09-28
Completion date
2026-09-28
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Invasive

Brief summary

This is a real-world multicentre study to investigate the metastatic pattern of axillary lymph node and its association with breast cancer prognosis.

Interventions

PROCEDUREALND

axillary lymph node dissection

Sponsors

Wenjin Yin
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 years or older * Pathologically confirmed invasive primary breast cancer

Exclusion criteria

* De novo stage IV breast cancer

Design outcomes

Primary

MeasureTime frameDescription
Disease free survivalFrom the date of axillary lymph node dissection until time of event up to 3 yearsDisease-free survival time is defined as the time from the date of axillary lymph node dissection until the date of the first occurrence of local/regional relapse, distant recurrence, contralateral breast cancer, second malignancy and death from any cause.

Secondary

MeasureTime frameDescription
Recurrence-free survivalFrom the date of axillary lymph node dissection until time of event up to 3 yearsRecurrence-free survival time is defined as the time from the date of axillary lymph node dissection until the date of the first occurrence of local/regional recurrence, distant recurrence and death from any cause
Overall survivalFrom the date of axillary lymph node dissection until time of event up to 3 yearsOverall survival time is defined as the time from the date of axillary lymph node dissection until death from any cause

Countries

China

Contacts

PRINCIPAL_INVESTIGATORWenjin Yin, M.D.

Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026